Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
XLCare Pharmaceuticals is an active US-based generic pharmaceutical manufacturer focused on providing high-quality and affordable medicines. The company's portfolio includes commercialized generics for various therapeutic areas such as psychiatry (aripiprazole), pain management (hydrocodone/acetaminophen), cardiovascular disease (losartan potassium), HIV/AIDS (lamivudine and zidovudine), among others. There are no clinical-stage or proprietary pipeline programs; all products are approved generics[1][5][10].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on XLCare Pharmaceuticals.